VENN STRATEGIES, LLC

Lobbying for TRIS PHARMA, INC. · Biopharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate · $200,000.00 income · posted Jul 18, 2025

Lobbying activity 1

Health Issues

Policy activities related to treatment of ADHD.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem